131 assets in Metabolic Dysfunction-Associated Steatotic Liver Disease

Therapeutic assets addressing Metabolic Dysfunction-Associated Steatotic Liver Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dapagliflozin Metabolic Dysfunction-Associated Steatotic Liver Disease	Post Graduate Institute of Medical Education and Research, Chandigarh	P4	BBB (77)
Metformin Metabolic Dysfunction-Associated Steatotic Liver Disease	Xiqiao Zhou	P4	BBB (74)
Empagliflozin Metabolic Dysfunction-Associated Steatotic Liver Disease	Justin Ryder	P4	BBB (73)
Pioglitazone Metabolic Dysfunction-Associated Steatotic Liver Disease	Badr University	P4	BBB (73)
Tirzepatide Metabolic Dysfunction-Associated Steatotic Liver Disease	Regeneron Pharmaceuticals	P3	BBB (72)
Saroglitazar Metabolic Dysfunction-Associated Steatotic Liver Disease	Zydus Lifesciences Limited	P4	BB (70)
Semaglutide Metabolic Dysfunction-Associated Steatotic Liver Disease	Shanghai Jiao Tong University School of Medicine	P4	BB (69)
Silymarin Metabolic Dysfunction-Associated Steatotic Liver Disease	University Hospitals Cleveland Medical Center	P4	BB (69)
Umbellatine Metabolic Dysfunction-Associated Steatotic Liver Disease	China National Center for Cardiovascular Diseases	P4	BB (69)
Liraglutide Metabolic Dysfunction-Associated Steatotic Liver Disease	Affiliated Hospital of Nantong University	P4	BB (68)
Rybelsus Metabolic Dysfunction-Associated Steatotic Liver Disease	Zagazig University	P4	BB (68)
Ursodeoxycholic Acid Metabolic Dysfunction-Associated Steatotic Liver Disease	Phenomen Pharma	P4	BB (67)
Amino Acids,Essential Metabolic Dysfunction-Associated Steatotic Liver Disease	Michigan State University	P3	BB (66)
Denifanstat Metabolic Dysfunction-Associated Steatotic Liver Disease	Sagimet Biosciences Inc.	P3	BB (66)
Febuxostat Metabolic Dysfunction-Associated Steatotic Liver Disease	Ain Shams University	P4	BB (66)
Rifaximin Metabolic Dysfunction-Associated Steatotic Liver Disease	Shanghai Changzheng Hospital	P4	BB (66)
Aln-Pnp Metabolic Dysfunction-Associated Steatotic Liver Disease	Regeneron Pharmaceuticals	P2	BB (65)
Alogliptin Metabolic Dysfunction-Associated Steatotic Liver Disease	The Fourth Affiliated Hospital of Zhejiang University School of Medicine	P4	BB (65)
Atorvastatin Metabolic Dysfunction-Associated Steatotic Liver Disease	Badr University	P4	BB (65)
Dulaglutide Metabolic Dysfunction-Associated Steatotic Liver Disease	Seoul National University Bundang Hospital	P4	BB (65)
Goserelin Metabolic Dysfunction-Associated Steatotic Liver Disease	Aristotle University Of Thessaloniki	P4	BB (65)
Henagliflozin Metabolic Dysfunction-Associated Steatotic Liver Disease	Xiqiao Zhou	P4	BB (65)
Alpha Tocopherol Metabolic Dysfunction-Associated Steatotic Liver Disease	Hawler Medical University	P3	BB (64)
Sitagliptin Metabolic Dysfunction-Associated Steatotic Liver Disease	University Health Network, Toronto	P4	BB (64)
Acetylcysteine Metabolic Dysfunction-Associated Steatotic Liver Disease	Ain Shams University	P3	B (63)
Denosumab Metabolic Dysfunction-Associated Steatotic Liver Disease	Aristotle University Of Thessaloniki	P4	B (63)
Serostim Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P2	B (63)
Actos Metabolic Dysfunction-Associated Steatotic Liver Disease	Zagazig University	P4	B (62)
Alendronic Acid Metabolic Dysfunction-Associated Steatotic Liver Disease	Aristotle University Of Thessaloniki	P4	B (62)
Paliperidone Metabolic Dysfunction-Associated Steatotic Liver Disease	Consorcio Centro de Investigación Biomédica en Red (CIBER)	P4	B (62)
Resmetirom Metabolic Dysfunction-Associated Steatotic Liver Disease	Naga P. Chalasani	P3	B (62)
Tocopherol Metabolic Dysfunction-Associated Steatotic Liver Disease	Zagazig University	P4	B (62)
dd01 Metabolic Dysfunction-Associated Steatotic Liver Disease	Neuraly, Inc.	P2	B (61)
Efinopegdutide Metabolic Dysfunction-Associated Steatotic Liver Disease	Merck Sharp & Dohme LLC	P2	B (60)
Efruxifermin Metabolic Dysfunction-Associated Steatotic Liver Disease	Akero Therapeutics, Inc	P3	B (60)
Mazdutide Metabolic Dysfunction-Associated Steatotic Liver Disease	Innovent Biologics (Suzhou) Co. Ltd.	P3	B (60)
Retatrutide Metabolic Dysfunction-Associated Steatotic Liver Disease	Eli Lilly and Company	P3	B (60)
Allopurinol Metabolic Dysfunction-Associated Steatotic Liver Disease	Ain Shams University	P4	B (59)
Canagliflozin Metabolic Dysfunction-Associated Steatotic Liver Disease	Ping Li,MD	P4	B (59)
Efimosfermin Alfa Metabolic Dysfunction-Associated Steatotic Liver Disease	GlaxoSmithKline	P3	B (59)
Msdc-0602K Metabolic Dysfunction-Associated Steatotic Liver Disease	Cirius Therapeutics, Inc.	P3	B (59)
Orlistat Metabolic Dysfunction-Associated Steatotic Liver Disease	Affiliated Hospital of Nantong University	P4	B (59)
asc41 Metabolic Dysfunction-Associated Steatotic Liver Disease	Gannex Pharma Co., Ltd.	P2	B (58)
Obeticholic Acid Metabolic Dysfunction-Associated Steatotic Liver Disease	King Edward Medical University	P2	B (58)
Fenofibrate Metabolic Dysfunction-Associated Steatotic Liver Disease	Yokohama City University	P2	B (57)
Lum-201 Metabolic Dysfunction-Associated Steatotic Liver Disease	Massachusetts General Hospital	P2	B (57)
Proliverenol Metabolic Dysfunction-Associated Steatotic Liver Disease	Dexa Medica Group	P2	B (57)
Rencofilstat Metabolic Dysfunction-Associated Steatotic Liver Disease	Hepion Pharmaceuticals, Inc.	P2	B (57)
Trimetazidine Metabolic Dysfunction-Associated Steatotic Liver Disease	October 6 University	P2	B (57)
Vigabatrin Metabolic Dysfunction-Associated Steatotic Liver Disease	Washington University School of Medicine	P2	B (57)

Showing 1 to 50 of 131 assets

PreviousPage 1 of 3Next